Botox is a prescription drug that’s used to treat certain bladder problems, such as overactive bladder (OAB) in adults. For certain bladder problems, Botox may also be prescribed to children ...

The two most common types are stress urinary incontinence, which may be caused by weakened pelvic floor muscles, and overactive bladder, which can be the result of menopause, aging, or damage to ...

The bladder is essential to our body’s urinary system, regulating the storage and release of urine. Much like diet affects ...

Luke Massella is one of about 10 people alive walking around with a replacement bladder that has been grown from his own cells. He was born with a condition called spina bifida, which, from birth ...

If your symptoms are making your life difficult, surgery may be the answer. There are two types of surgery for bladder prolapse. Though you can't ensure you’ll never get urinary incontinence ...

After surgery, you will have a small catheter in place to help you empty your bladder, which can cause discomfort and ... The first time he experienced ED in his mid-50s he thought it was just a fluke ...

The first time he experienced ED in his mid-50s he thought it was just a fluke, which was a reasonable assumption to make. More than half of men experience episodic erectile dysfunction at some time ...

Anticholinergics are competitive inhibitors of acetylcholine at muscarinic receptors (mainly the M3 receptor subtype), and they thereby inhibit involuntary bladder contractions. [19] The effective ...

coli is present. It’s also shorter than that of MAABs, giving the bacteria easier access to the bladder, where the majority of UTIs occur, and the rest of the urinary tract. Some factors that ...

The bladder cancer team at Fred Hutchinson Cancer Center treats every type and stage of bladder cancer, from early to advanced. This includes rare variants that other physicians may never see. People ...

Oct 18 (Reuters) - Gilead Sciences (GILD.O), opens new tab said on Friday it was voluntarily withdrawing its drug, Trodelvy, for patients with a type of bladder cancer after it failed to meet the ...

After falling short in a confirmatory clinical trial, Gilead Sciences has decided to withdraw Trodelvy as a bladder cancer treatment in the U.S. The California biotech announced the decision ...